CABOTRIM 0.5

Land: Israël

Taal: Engels

Bron: Ministry of Health

Werkstoffen:

CABERGOLINE

Beschikbaar vanaf:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC-code:

N04BA

farmaceutische vorm:

TABLETS

Samenstelling:

CABERGOLINE 0.5 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Therapeutische categorie:

DOPA AND DOPA DERIVATIVES

therapeutische indicaties:

Treatment of hyperprolactinemic disorders.Cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. Cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. Inhibition and supression of lactation .

Autorisatie datum:

2021-11-30

Bijsluiter

P00001109
0522F
PIL-0322-04
P00001109
PIL-0322-04
0522F 0 3000
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
CABOTRIM 0.5
TABLETS
Each tablet contains:
Cabergoline 0.5 mg
Inactive ingredients: see section 6 ‘Further information’.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE.
This leaflet contains concise information about this medicine.
If you have any further questions, consult your doctor or
pharmacist.
This medicine has been prescribed for you. Do not pass it on
to others. It may harm them, even if it seems to you that their
medical condition is similar to yours.
1. WHAT IS THIS MEDICINE INTENDED FOR?
The medicine supresses production of prolactin and is indicated
for the treatment of hyperprolactinemia and to prevent/stop
breast milk production.
THERAPEUTIC GROUP:
Dopamine receptor agonist. . BEFORE USING THIS MEDICINE
DO NOT USE THIS MEDICINE IF:
you are sensitive (allergic) to cabergoline, other medicines
called ergot alkaloids (e.g. pergolide, bromocriptine, lisuride,
ergotamine or ergometrine) or to any of the other ingredients
of this medicine (see section 6).
you have severe liver disease.
you have high blood pressure in pregnancy associated with
swelling and protein in the urine (toxaemia of pregnancy).
you are being treated with anti-psychotics or have a history of
mental illness associated with child-birth (psychosis during or
after child-birth).
you are pregnant or breastfeeding.
you will be treated for a long period and have stiff or inflamed
heart valves (cardiac valvulopathy).
you have had fibrotic reactions (scar tissue) affecting your
abdomen, heart or lungs.
SPECIAL WARNINGS REGARDING USE OF THE MEDICINE
BEFORE TREATMENT WITH CABOTRIM 0.5, TELL YOUR DOCTOR IF YOU
HAVE OR HAD ANY OF THE FOLLOWING MEDICAL CONDITIONS:
Disease
that
involves
the
heart
and
blood
vessels
(cardiovascular disease)
Cold hands and feet (Raynaud’s syndrome)
Gnawing pain in the abdomen when hungry